Background The widespread use of Immune checkpoint-inhibitors (ICI) has revolutionised
treatment of multiple cancer types. However, selecting patients who may benefit from ICI …

Artificial intelligence (AI) is becoming increasingly important, especially in the medical field.
While AI has been used in medicine for some time, its growth in the last decade is …

Simple Summary Lactate dehydrogenase (LDH) levels prior to treatment are a known
biomarker to predict advanced melanoma's response to immune checkpoint inhibitors (ICI) …

Background The emergence of immunotherapy has changed the treatment modality for
melanoma and prolonged the survival of many patients. However, a handful of patients …

Gastric cancer is a malignant disease with a poor prognosis and few therapeutic options
once it has advanced. Immunotherapy using ICIs has emerged as a viable therapeutic …

Skin melanoma is a lethal cancer. The incidence of melanoma is increasing rapidly in all
regions of the world. Despite significant breakthroughs in melanoma treatment in recent …

Background Melanoma is one of the most fatal forms of skin cancer. Defining relevant
biomarkers to predict treatment outcome based on immune checkpoint inhibitors (ICIs) is …

Advances in immune checkpoint and combination therapy have led to improvement in
overall survival for patients with advanced melanoma. Improved understanding of the tumor …

Abstract Aim To evaluate Stereotactic body radiotherapy (SBRT) in metastatic colorectal
cancer (mCRC) and identify the benefit of the treatment by using a predictive algorithm …